deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT03317613

Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic Pain (CAPSONCO)

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Interventions Qutenza
Updated 9 times since 2017 Last updated: Feb 7, 2022 Started: Nov 9, 2017 Primary completion: Dec 4, 2020 Completion: Dec 20, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Neuropathic Pain and is currently completed. Centre Hospitalier Universitaire de Saint Etienne leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshotNot Yet Recruiting~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotRecruiting~Jun 2018 – ~May 2019 · 11 months · monthly snapshotRecruiting~May 2019 – ~Feb 2020 · 9 months · monthly snapshotRecruiting~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotActive Not Recruiting~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Mar 2022 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not RecruitingCompleted

  4. Jan 2021 — Mar 2022 [monthly]

    Active Not Recruiting PHASE2

    Status: RecruitingActive Not Recruiting

  5. Feb 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

Show 4 earlier versions
  1. May 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  2. Jun 2018 — May 2019 [monthly]

    Recruiting PHASE2

  3. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  4. Nov 2017 — Dec 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de Saint Etienne
  • Institut de Cancérologie de la Loire
Data source: Centre Hospitalier Universitaire de Saint Etienne

For direct contact, visit the study record on ClinicalTrials.gov .